SteriMax Announces Canadian launch of Octreotide Depot (Octreotide for Injectable Suspension)​

As the only commercially available generic alternative to Sandostatin LAR® in Canada, Octreotide Depot provides healthcare professionals and patients with an affordable treatment option for long-term disease management. The launch of Octreotide Depot reflects SteriMax’s commitment to improving access to critical injectable medicines and strengthening the availability of high-quality therapeutic solutions for Canadians.